Loading company…
Riskpilot
← Back to search
Sign in
Get full access
FURUSETH BIOKONSULT AS
AS
Active
Org 831082402
Biskop Heuchs vei 38B, 0871 Oslo
Engineering activities and related technical consultancy · NACE 7112
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 807K
-26% vs 2024
EBITDA margin
31.3%
-60% vs 2024
Equity ratio
88.1%
Financial strength
Net profit 2025
NOK 279K
-50% vs 2024
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2023
1M
0%
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
NOK 807K
-26%
EBITDA
NOK 253K
-60%
Net profit
NOK 279K
-50%
Total assets
NOK 1,5M
-4%
Equity
NOK 1,3M
+27%
Employees
0
—
Company information
Legal name
FURUSETH BIOKONSULT AS
Org number
831082402
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
22. mars 2023
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Teknisk rådgivning og prosjektledelse.
Contact
Address
Biskop Heuchs vei 38B, 0871 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Engineering activities and related technical consultancy
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
1M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
0M
2025
Income statement
NOK thousands
Item
2023
2024
2025
Revenue
1 029
1 086
807
Staff expenses
−0
−211
−332
EBITDA
946
632
253
Depreciation & amort.
−0
−0
−0
EBIT
946
632
253
Net financials
−2
64
78
Profit before tax
943
695
331
Tax
206
136
52
Net profit
737
559
279
Balance sheet
NOK thousands
Item
2023
2024
2025
Total assets
988
1 536
1 474
Equity
760
1 019
1 298
Long-term debt
0
0
0
Short-term debt
228
517
176
Total debt
228
517
176
Financial ratios
5-year trend
EBITDA margin
31.3%
This company
15.8%
Market median
+98% vs market
2023
2025
Equity ratio
88.1%
This company
38.2%
Market median
+131% vs market
2023
2025
Return on equity
21.5%
This company
18.4%
Market median
+17% vs market
2023
2025
Net profit margin
34.6%
This company
8.1%
Market median
+327% vs market
2023
2025
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
2023
2025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
KO
Knut Olav Furuseth
Chairman
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of FURUSETH BIOKONSULT AS also hold positions in
0
other companies.
Person
Role here
Other companies
Knut Olav Furuseth
Chairman
0 companies